All News

The FDA granted fast track designation to NG-350A for the treatment of patients with mismatch repair-proficient locally advanced rectal cancer.

A study found exercise after treatment boosts cancer survival, prompting experts to call for structured movement as a standard part of survivorship care.

Patients with advanced renal cell carcinoma whose disease has progressed on first-line therapies may benefit from the combination of Fruzaqla and Tyvyt.

Patients living with myelofibrosis who also experience anemia may see meaningful improvements in blood counts when treated with Vonjo.

Dr. Anjana Pillai highlights Liver Cancer Awareness Month’s role in promoting liver health, dispelling myths and encouraging early detection and care.

Thoughts on life, multiple myeloma, architecture and Douglas Adams.

CURE spoke with Betsy Hamlin, who was treated with Keytruda Qlex in a clinical trial after being diagnosed with melanoma.

The FDA granted breakthrough therapy designation to sonrotoclax for adults with relapsed or refractory mantle cell lymphoma, based on phase 1/2 data.

Dr. Komal Jhaveri says Breast Cancer Awareness Month should move beyond pink ribbons to drive early detection, research and equitable care.

While Breast Cancer Awareness Month raises funds and awareness, for survivors, it can painfully remind them of all they’ve endured.

The challenges of being diagnosed with a rare cancer are real, but so is the strength that comes from thriving through it.

Dr. Evan Garfein explains how 3D printing and tissue-engineered implants could make breast reconstruction safer and less taxing on the body.

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

CURE spoke with Dr. Komal Jhaveri about the findings of the EMBER-3 clinical trial.

Pelvic health therapist Dr. Alison Ankiewicz helps women manage pain, intimacy issues and bladder or bowel problems that can follow cancer treatment.

CURE spoke with melanoma survivor Betsy Hamlin about her experience with subcutaneous Keytruda in a clinical trial.

Dr. Evan Garfein discussed OnPlant, a 3D breast model, and stressed timely reconstructive care for all patients during Breast Cancer Awareness Month.

Dr. Ravi Munver discusses how minimally invasive techniques allow patients to preserve kidney function and practical guidance for navigating treatment.

This guide provides a supportive overview of stage 2 melanoma, covering diagnosis, treatment options, and key questions for your medical team.

The DONNA Foundation will host its signature fall event, the DONNA 5K at TPC Sawgrass.

Sarcoma is a rare cancer of connective tissues that requires specialized diagnosis and care tailored to tumor type, stage, and patient needs.

Although a cancer diagnosis can feel overwhelming and isolating, patients should know that they are never alone, Brittney Nichols emphasized.

I share my journey facing breast cancer at 39, learning my numbers, trusting my doctor, and becoming my own advocate for informed treatment choices.

Jennie Smythe continues the conversation following her initial discussion on early detection self-advocacy during Breast Cancer Awareness Month.

The FDA granted fast track status to ADCE-D01, a targeted drug in early trials for soft tissue sarcoma, to speed development and review.

From diagnosis to treatment, here is what patients need to know about stage 1 testicular cancer.

Understand why early detection gives you the best chance, explore your surgery or radiation options, and plan for survivorship with oral cavity cancer.